Home > Financial Ratios > LACTOSE (INDIA)

LACTOSE (INDIA)
Core EBITDA Growth

    Back to All Ratios
LACTOSE (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -8.5666.44-5.7996.48-31.65

What is the latest Core EBITDA Growth ratio of LACTOSE (INDIA) ?

The latest Core EBITDA Growth ratio of LACTOSE (INDIA) is -8.56 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-8.56
Mar202466.44
Mar2023-5.79
Mar202296.48
Mar2021-31.65

How is Core EBITDA Growth of LACTOSE (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2025 -8.56
Negative
Mar2024 66.44
Positive
Mar2023 -5.79
Negative
Mar2022 96.48
Positive
Mar2021 -31.65 -

Other Financial Ratios of LACTOSE (INDIA)


Compare Core EBITDA Growth ratio of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹129.0 Cr -6.1% -3.8% -18.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹240,780.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,828.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹109,305.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹108,759.0 Cr -0.6% 1% -0.1% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

-6.1%

-3.8%

-18.3%

SENSEX

-1.5%

-1.2%

-11.8%


You may also like the below Video Courses